KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Non-Current Assets (2019 - 2025)

GoodRx Holdings' Non-Current Assets history spans 7 years, with the latest figure at -$565.5 million for Q3 2025.

  • For Q3 2025, Non-Current Assets changed N/A year-over-year to -$565.5 million; the TTM value through Sep 2025 reached $347.9 million, changed N/A, while the annual FY2024 figure was $728.8 million, 1.79% up from the prior year.
  • Non-Current Assets for Q3 2025 was -$565.5 million at GoodRx Holdings, down from -$540.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $772.8 million in Q2 2023 and bottomed at -$565.5 million in Q3 2025.
  • The 5-year median for Non-Current Assets is $684.9 million (2022), against an average of $475.8 million.
  • The largest annual shift saw Non-Current Assets soared 53.89% in 2021 before it dropped 6.21% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $518.8 million in 2021, then surged by 32.03% to $684.9 million in 2022, then grew by 4.54% to $716.0 million in 2023, then rose by 1.79% to $728.8 million in 2024, then plummeted by 177.59% to -$565.5 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Non-Current Assets are -$565.5 million (Q3 2025), -$540.2 million (Q1 2025), and $728.8 million (Q4 2024).